Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1954 2
1955 5
1956 3
1957 5
1958 6
1959 9
1960 5
1961 7
1962 7
1963 24
1964 21
1965 15
1966 24
1967 33
1968 25
1969 29
1970 18
1971 20
1972 29
1973 36
1974 40
1975 26
1976 28
1977 27
1978 19
1979 20
1980 19
1981 27
1982 14
1983 23
1984 14
1985 17
1986 14
1987 11
1988 10
1989 10
1990 4
1991 8
1992 17
1993 11
1994 9
1995 6
1996 19
1997 50
1998 57
1999 61
2000 45
2001 25
2002 26
2003 20
2004 10
2005 19
2006 23
2007 13
2008 12
2009 15
2010 25
2011 33
2012 47
2013 62
2014 63
2015 40
2016 48
2017 44
2018 42
2019 42
2020 46
2021 33
Text availability
Article attribute
Article type
Publication date

Search Results

1,547 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacotherapy for obesity.
Lee PC, Dixon J. Lee PC, et al. Aust Fam Physician. 2017;46(7):472-477. Aust Fam Physician. 2017. PMID: 28697290 Free article.
Obesity: Pharmacotherapy.
Powell A. Powell A. FP Essent. 2020 May;492:25-29. FP Essent. 2020. PMID: 32383845
Currently, five drugs are approved for weight management in adults: phentermine, orlistat, phentermine-topiramate, bupropion-naltrexone, and liraglutide. ...
Currently, five drugs are approved for weight management in adults: phentermine, orlistat, phentermine-topiramate, bupropion-n …
Phentermine/topiramate for the treatment of obesity.
Smith SM, Meyer M, Trinkley KE. Smith SM, et al. Ann Pharmacother. 2013 Mar;47(3):340-9. doi: 10.1345/aph.1R501. Ann Pharmacother. 2013. PMID: 23482732 Review.
OBJECTIVE: To review the pharmacology, efficacy, and safety of phentermine/topiramate (PHEN/TPM) in the management of obese patients. DATA SOURCES: MEDLINE (1966-July 2012) was searched using the terms weight loss, obesity, phentermine and topiramate, phentermine
OBJECTIVE: To review the pharmacology, efficacy, and safety of phentermine/topiramate (PHEN/TPM) in the management of obese patients. …
In brief: Phentermine (Lomaira) for weight loss.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2016 Dec 5;58(1509):158. Med Lett Drugs Ther. 2016. PMID: 27906152 Review. No abstract available.
Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release.
Halpern B, Mancini MC. Halpern B, et al. Expert Opin Drug Saf. 2017 Jan;16(1):27-39. doi: 10.1080/14740338.2017.1247807. Epub 2016 Oct 24. Expert Opin Drug Saf. 2017. PMID: 27732121 Review.
Few studies on combination therapies for the treatment of obesity had been conducted until recently, when two fixed-dose combinations, bupropion-naltrexone ER fixed-dose combination and phentermine-topiramate ER titrated-dose combinations were evaluated in clinical studies …
Few studies on combination therapies for the treatment of obesity had been conducted until recently, when two fixed-dose combinations, bupro …
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.
Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, Schwiers M, Day WW, Bowden CH. Garvey WT, et al. Am J Clin Nutr. 2012 Feb;95(2):297-308. doi: 10.3945/ajcn.111.024927. Epub 2011 Dec 7. Am J Clin Nutr. 2012. PMID: 22158731 Free PMC article. Clinical Trial.
BACKGROUND: Obesity is a serious chronic disease. Controlled-release phentermine/topiramate (PHEN/TPM CR), as an adjunct to lifestyle modification, has previously shown significant weight loss compared with placebo in a 56-wk study in overweight and obese subjects with 2 w …
BACKGROUND: Obesity is a serious chronic disease. Controlled-release phentermine/topiramate (PHEN/TPM CR), as an adjunct to lifestyle …
A randomized, placebo-controlled crossover trial of phentermine-topiramate ER in patients with binge-eating disorder and bulimia nervosa.
Safer DL, Adler S, Dalai SS, Bentley JP, Toyama H, Pajarito S, Najarian T. Safer DL, et al. Int J Eat Disord. 2020 Feb;53(2):266-277. doi: 10.1002/eat.23192. Epub 2019 Nov 13. Int J Eat Disord. 2020. PMID: 31721257 Clinical Trial.
OBJECTIVE: Open trials suggest phentermine/topiramate ER (PHEN/TPM-ER), food and drug administration (FDA) approved for obesity, has utility for binge eating. ...
OBJECTIVE: Open trials suggest phentermine/topiramate ER (PHEN/TPM-ER), food and drug administration (FDA) approved for obesity, has …
Topiramate-phentermine combinations reduce cocaine self-administration in humans.
Rush CR, Stoops WW, Lile JA, Alcorn JL 3rd, Bolin BL, Reynolds AR, Hays LR, Rayapati AO. Rush CR, et al. Drug Alcohol Depend. 2021 Jan 1;218:108413. doi: 10.1016/j.drugalcdep.2020.108413. Epub 2020 Nov 23. Drug Alcohol Depend. 2021. PMID: 33290875
Combining topiramate and phentermine robustly decreased cocaine self-administration. Topiramate and phentermine were well tolerated alone and combined, as well as in conjunction with cocaine. CONCLUSIONS: The results of the present study support advancing topiramate …
Combining topiramate and phentermine robustly decreased cocaine self-administration. Topiramate and phentermine were well tole …
Coronary Vasospasm Induced by Phentermine.
Franke KB, Psaltis PJ. Franke KB, et al. Mayo Clin Proc. 2019 Jul;94(7):1138-1140. doi: 10.1016/j.mayocp.2019.05.021. Mayo Clin Proc. 2019. PMID: 31272562 No abstract available.
[Phentermine--a "weighty" or a dangerous substance?].
Skopp G, Jantos R. Skopp G, et al. Arch Kriminol. 2013 Mar-Apr;231(3-4):116-29. Arch Kriminol. 2013. PMID: 23678625 Review. German.
Phentermine is an isomer of methamphetamine though is not optically active such as e. g. amphetamine. ...Due to its declining effect with time and its addiction potential it has been recommended that phentermine should be used for a few weeks only. Phentermine
Phentermine is an isomer of methamphetamine though is not optically active such as e. g. amphetamine. ...Due to its declining effect
1,547 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page